Vinracine is an anticancer injection used to treat a range of tumors, including breast cancer, lymphoma, and testicular cancer. It contains vinblastine, a plant alkaloid, which inhibits the division of cancer cells by affecting microtubules, which play a key role in cell division. This inhibits tumor growth and destroys malignant cells. This medication is administered intravenously under the supervision of a specialist physician in precise doses depending on the patient's condition. The patient must be monitored continuously because
Vinracine injection may cause a severe decrease in white blood cells and platelets, which increases the risk of infection and bleeding.